Patent details

EN | LT

LT - Trans-4-{2-[4-(2,3-dichlorfenil)-piperazin-1-il]-etil}-N,N-dimetilkarbamoil-cikloheksilaminas, skirtas pirminių neigiamų šizofrenijos simptomų gydymui

EN - TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

Legal status

Patent in force

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/495	(2006.01)
		A61P 25/18	(2006.01)

European patent
(11)	Number of the document	2925324
(13)	Kind of document	T
(96)	European patent application number	13805597.5
	Date of filing the European patent application	2013-11-28
(97)	Date of publication of the European application	2015-10-07
(45)	Date of publication and mention of the grant of the patent	2020-12-30
(46)	Date of publication of the claims translation	2021-02-25

PCT application
(86)	Number	PCT/IB2013/060465
	Date	2013-11-28

PCT application publication
(87)	Number	WO 2014/083522
	Date	2014-06-05

Priority applications
(30)	Number	Date	Country code
	P1200691	2012-11-29	HU

Inventors
(72)	PITTER, Janos György, HU SZATMARI, Balazs, HU DEBELLE, Marc, FR NÉMETH, György Jozsef, HU LASZLOVSZKY, Istvan, HU

Grantee
(73)	Richter Gedeon Nyrt., Gyömröi ut 19-21., 1103 Budapest, HU

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Title
(54)	Trans-4-{2-[4-(2,3-dichlorfenil)-piperazin-1-il]-etil}-N,N-dimetilkarbamoil-cikloheksilaminas, skirtas pirminių neigiamų šizofrenijos simptomų gydymui
	TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

Last renewal fee
	Payment date	Validity (years)	Amount
	2024-10-25	12	289.00 EUR

Next renewal fee
	2025-11-28